A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer

The heterogeneity in prognoses and chemotherapeutic responses of colon cancer patients with similar clinical features emphasized the necessity for new biomarkers that help to improve the survival prediction and tailor therapies more rationally and precisely. In the present study, we established a st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui, Sun, Huiying, Zheng, Siting, Zhang, Jingwen, Zeng, Dongqiang, Wu, Jianhua, Huang, Zhenhua, Rong, Xiaoxiang, Bin, Jianping, Liao, Yulin, Shi, Min, Liao, Wangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077592/
https://www.ncbi.nlm.nih.gov/pubmed/31989761
http://dx.doi.org/10.1111/jcmm.14999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077592/
https://www.ncbi.nlm.nih.gov/pubmed/31989761
http://dx.doi.org/10.1111/jcmm.14999

Ejemplares similares